We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TCRT icon
526
Alaunos Therapeutics
TCRT
$4.95M
$4.95M $1.95 3.17%
CDIO icon
527
Cardio Diagnostics
CDIO
$4.94M
$4.94M $1.67 4.57%
XBIO icon
528
Xenetic Biosciences
XBIO
$4.8M
$4.8M $2.05 3.3%
TRAW icon
529
Traws Pharma
TRAW
$4.55M
$4.55M $0.2960 1.66%
NCNA icon
530
NuCana
NCNA
$4.2M
$4.2M $1.01 2.88%
XTLB icon
531
XTL Biopharmaceuticals
XTLB
$3.96M
$3.96M $1.61 8.52%
DRMA icon
532
Dermata Therapeutics
DRMA
$3.84M
$3.84M $0.7750 7.86%
LIMN
533
Liminatus Pharma
LIMN
$3.79M
$3.79M $2.82 2.76%
NRSN icon
534
NeuroSense Therapeutics
NRSN
$3.77M
$3.77M $1.99 6.57%
JAGX icon
535
Jaguar Health
JAGX
$3.76M
$3.76M $1.62 20.6%
CVKD icon
536
Cadrenal Therapeutics
CVKD
$3.51M
$3.51M $0.9850 4.41%
GRI icon
537
GRI Bio
GRI
$3.34M
$3.34M $1.53 2.55%
EOCN icon
538
Eocene Ltd. Ordinary Shares
EOCN
$3.31M
$3.31M $3.10 3.73%
SXTP icon
539
60 Degrees Pharmaceuticals
SXTP
$3.31M
$3.31M $0.9400 0.79%
ONCO icon
540
Onconetix
ONCO
$3.3M
$3.3M $0.5610 4.27%
PMCB icon
541
PharmaCyte Biotech
PMCB
$3.24M
$3.24M $0.3021 9.03%
KALA icon
542
KALA BIO
KALA
$3.2M
$3.2M $0.1655 5.48%
CMND icon
543
Clearmind Medicine
CMND
$3.16M
$3.16M $6.22 6.32%
MBIO icon
544
Mustang Bio
MBIO
$3.03M
$3.03M $0.4001 1.94%
ENLV icon
545
Enlivex Ltd
ENLV
$2.73M
$2.73M $1.78 29.9%
SILO icon
546
Silo Pharma
SILO
$2.71M
$2.71M $1.23 1.6%
JUNS
547
Jupiter Neurosciences
JUNS
$2.7M
$2.7M $2.05 13.5%
HCWB icon
548
HCW Biologics
HCWB
$2.46M
$2.46M $1.10 6.78%
APVO icon
549
Aptevo Therapeutics
APVO
$2.43M
$2.43M $1.34 1.47%
ERNA icon
550
Eterna Therapeutics
ERNA
$2.3M
$2.3M $1.97 6.64%
19 20 21
22
23

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 572 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.